Company: LHI
Filing Date: 2025-09-29
Form Type: F-1/A
Source: 0001213900-25-092499
Chunk: 126

Company: Living Homeopathy International Ltd.
Filing Date: 2025-09-29
Form: F-1/A
Chunk 126
---
 Sales Revenue (Hong Kong), 2019-2029E</div>

Source: Frost & Sullivan Report

The Company specializes in T&CM products
within the categories of homeopathic remedies, co-remedies, and classical flower remedies, addressing consumer demand for healthcare
products. Therefore, the broader T&CM market trends, including acupuncture, yoga, meditation, and chiropractic care, fall outside
the Company’s business scope. Growth projections for the overall T&CM market in Hong Kong are not directly applicable to the
Company’s business.

<div align='center'>67</div>

Growth Drivers

The Traditional and Complementary Medicine (T&CM)
market in Hong Kong could potentially benefit from the following three (3) major growth drivers:

| ● | Rising                                                                                                                                      
 in the prevalence of chronic diseases. Chronic diseases significantly contribute to the expansion of the Traditional and Complementary      
 Medicine (T&CM) market in Hong Kong. The increasing prevalence of conditions like diabetes, asthma, and depression, which rose              
 from 19.2% in 2013 to 24.1% in 2020, drives demand for holistic management approaches offered by T&CM. Some customers with chronic          
 diseases may prefer natural and non-invasive therapies, such as homeopathy and herbal medicine, over conventional treatments. Additionally, 
 T&CM’s emphasis on personalized treatment plans and preventive health measures could appeal to individuals managing chronic                 
 conditions. Rising healthcare costs and the need for mental health support associated with chronic diseases could also factor into          
 customers’ decision to choose T&CM therapies.                                                                                               |

| ● | Increasing                                                                                                                          
 aging population. Hong Kong’s aging demographic is more inclined to seek Traditional and Complementary therapies for chronic        
 conditions and age-related issues. As of 2023, 21.4% of Hong Kong’s population is aged 65 and above, a substantial increase         
 from 5% fifty years ago. Some older adults may be more inclined to seek T&CM therapies to manage chronic conditions and age-related 
 issues. T&CM’s holistic and non-invasive approaches could be appealing to the elderly, who often face multiple health challenges.   
 This demographic shift towards an aging population can potentially boost the demand for personalized and preventive T&CM therapies, 
 thereby driving market expansion.                                                                                                   |

| ● | Enhancing                                                                                            
 cultural acceptance towards T&CM. Long-standing cultural acceptance of Traditional                   
 Chinese Medicine and other T&CM practices supports market growth. Traditional                        
 Chinese Medicine is deeply